Aqua-Spark snaps up stake in 'undervalued' Hofseth BioCare, enters listed market for first time

The Dutch investment fund believes Hofseth's potential is significant and undervalued by public markets.

"We have stepped into the listed market for the first time as we believe that this company's potential is significant and undervalued by public markets on a long-term view," said Amy Novogratz, managing partner at Dutch aquaculture investment fund Aqua-Spark. — "We have stepped into the listed market for the first time as we believe that this company's potential is significant and undervalued by public markets on a long-term view," said Amy Novogratz, managing partner at Dutch aquaculture investment fund Aqua-Spark.Photo: Aqua-Spark

Dominic Welling

Published 4 November 2021, 16:11Updated 4 November 2021, 18:10

Aqua-Spark Investments Hofseth Biocare Roger Hofseth Norway